Advertisement
Screener

Oncotelic Therapeutics, Inc. (OTLC) Scorecard

2.8 / 5 stars · 68/120 Roast Me

Oncotelic Therapeutics, Inc. (OTLC) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
15/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseOTLC / S&P
0.00% / 15.20%
LoseOTLC / S&P
OTLC unavailable / 15.00%
LoseOTLC / S&P
OTLC unavailable / 50.40%
2026-Q10/3 LoseOTLC / S&P
-50.00% / -4.33%
LoseOTLC / S&P
OTLC unavailable / 11.30%
LoseOTLC / S&P
OTLC unavailable / 27.70%
2025-Q40/3 LoseOTLC / S&P
0.00% / 2.65%
LoseOTLC / S&P
OTLC unavailable / 9.00%
LoseOTLC / S&P
OTLC unavailable / 13.40%
2025-Q31/3 WinOTLC / S&P
100.00% / 8.12%
LoseOTLC / S&P
OTLC unavailable / 4.61%
LoseOTLC / S&P
OTLC unavailable / 13.45%
2025-Q20/3 LoseOTLC / S&P
-42.86% / 10.94%
LoseOTLC / S&P
OTLC unavailable / 4.83%
LoseOTLC / S&P
OTLC unavailable / 10.63%
2025-Q11/3 WinOTLC / S&P
75.00% / -4.27%
LoseOTLC / S&P
OTLC unavailable / 4.98%
LoseOTLC / S&P
OTLC unavailable / 10.57%
2024-Q41/3 WinOTLC / S&P
100.00% / 2.41%
LoseOTLC / S&P
OTLC unavailable / 5.25%
LoseOTLC / S&P
OTLC unavailable / 6.15%
2024-Q30/3 LoseOTLC / S&P
-33.33% / 5.89%
LoseOTLC / S&P
OTLC unavailable / 5.89%
LoseOTLC / S&P
OTLC unavailable / 6.11%
2024-Q20/3 LoseOTLC / S&P
-25.00% / 4.28%
LoseOTLC / S&P
OTLC unavailable / 5.38%
LoseOTLC / S&P
OTLC unavailable / 5.12%
2024-Q10/3 LoseOTLC / S&P
0.00% / 10.56%
LoseOTLC / S&P
OTLC unavailable / 5.71%
LoseOTLC / S&P
OTLC unavailable / 5.59%
2023-Q41/3 WinOTLC / S&P
33.33% / 11.69%
LoseOTLC / S&P
OTLC unavailable / 6.81%
LoseOTLC / S&P
OTLC unavailable / 7.78%
2023-Q31/3 WinOTLC / S&P
0.00% / -3.27%
LoseOTLC / S&P
OTLC unavailable / 7.52%
LoseOTLC / S&P
OTLC unavailable / -5.03%
2023-Q20/3 LoseOTLC / S&P
-40.00% / 8.74%
LoseOTLC / S&P
OTLC unavailable / 9.50%
LoseOTLC / S&P
OTLC unavailable / -8.57%
2023-Q10/3 LoseOTLC / S&P
0.00% / 7.50%
LoseOTLC / S&P
OTLC unavailable / 10.77%
LoseOTLC / S&P
OTLC unavailable / -15.69%
2022-Q40/3 LoseOTLC / S&P
-28.57% / 7.56%
LoseOTLC / S&P
OTLC unavailable / 11.88%
LoseOTLC / S&P
OTLC unavailable / -17.99%
2022-Q30/3 LoseOTLC / S&P
-58.82% / -4.88%
LoseOTLC / S&P
OTLC unavailable / 13.47%
LoseOTLC / S&P
OTLC unavailable / -1.41%
2022-Q20/3 LoseOTLC / S&P
-26.09% / -16.10%
LoseOTLC / S&P
OTLC unavailable / 13.71%
LoseOTLC / S&P
OTLC unavailable / 11.04%
2022-Q11/3 WinOTLC / S&P
35.29% / -4.60%
LoseOTLC / S&P
OTLC unavailable / 15.97%
LoseOTLC / S&P
OTLC unavailable / 42.23%
2021-Q41/3 WinOTLC / S&P
21.43% / 11.03%
LoseOTLC / S&P
OTLC unavailable / 15.00%
LoseOTLC / S&P
OTLC unavailable / 96.40%
2021-Q30/3 LoseOTLC / S&P
-36.36% / 0.58%
LoseOTLC / S&P
OTLC unavailable / 10.77%
LoseOTLC / S&P
OTLC unavailable / 69.42%
2021-Q20/3 LoseOTLC / S&P
-38.89% / 8.55%
LoseOTLC / S&P
OTLC unavailable / 6.58%
LoseOTLC / S&P
OTLC unavailable / 51.81%
2021-Q11/3 WinOTLC / S&P
63.64% / 6.17%
LoseOTLC / S&P
OTLC unavailable / -1.06%
LoseOTLC / S&P
OTLC unavailable / 7.39%
2020-Q41/3 WinOTLC / S&P
22.22% / 12.15%
LoseOTLC / S&P
OTLC unavailable / -3.72%
LoseOTLC / S&P
OTLC unavailable / -33.42%
2020-Q30/3 LoseOTLC / S&P
-5.26% / 8.93%
LoseOTLC / S&P
OTLC unavailable / -2.04%
LoseOTLC / S&P
OTLC unavailable / -27.10%
2020-Q20/3 LoseOTLC / S&P
11.76% / 20.54%
LoseOTLC / S&P
OTLC unavailable / -0.46%
LoseOTLC / S&P
OTLC unavailable / -27.11%
2020-Q11/3 WinOTLC / S&P
0.00% / -19.60%
LoseOTLC / S&P
OTLC unavailable / 3.47%
LoseOTLC / S&P
OTLC unavailable / -14.75%
2019-Q40/3 LoseOTLC / S&P
-39.29% / 9.07%
LoseOTLC / S&P
OTLC unavailable / 5.36%
LoseOTLC / S&P
OTLC unavailable / 2.99%
2019-Q31/3 WinOTLC / S&P
47.37% / 1.70%
LoseOTLC / S&P
OTLC unavailable / 5.02%
LoseOTLC / S&P
OTLC unavailable / 0.21%
2019-Q21/3 WinOTLC / S&P
72.73% / 4.30%
LoseOTLC / S&P
OTLC unavailable / 6.64%
LoseOTLC / S&P
OTLC unavailable / 8.65%
2019-Q11/3 WinOTLC / S&P
37.50% / 13.65%
LoseOTLC / S&P
OTLC unavailable / 8.12%
LoseOTLC / S&P
OTLC unavailable / 14.29%
2018-Q40/3 LoseOTLC / S&P
-52.94% / -13.52%
LoseOTLC / S&P
OTLC unavailable / 9.05%
LoseOTLC / S&P
OTLC unavailable / 18.23%
2018-Q30/3 LoseOTLC / S&P
-15.00% / 7.71%
LoseOTLC / S&P
OTLC unavailable / 10.21%
LoseOTLC / S&P
OTLC unavailable / 19.06%
2018-Q20/3 LoseOTLC / S&P
-23.08% / 3.43%
LoseOTLC / S&P
OTLC unavailable / 9.03%
LoseOTLC / S&P
OTLC unavailable / 14.46%
2018-Q11/3 WinOTLC / S&P
73.33% / -0.76%
LoseOTLC / S&P
OTLC unavailable / 7.68%
LoseOTLC / S&P
OTLC unavailable / 12.46%
2017-Q40/3 LoseOTLC / S&P
-40.00% / 6.64%
LoseOTLC / S&P
OTLC unavailable / 7.03%
LoseOTLC / S&P
OTLC unavailable / 13.82%
2017-Q30/3 LoseOTLC / S&P
-26.47% / 4.48%
LoseOTLC / S&P
OTLC unavailable / 5.68%
LoseOTLC / S&P
OTLC unavailable / 17.57%
2017-Q20/3 LoseOTLC / S&P
-55.84% / 3.09%
LoseOTLC / S&P
OTLC unavailable / 4.83%
LoseOTLC / S&P
OTLC unavailable / 17.74%
2017-Q11/3 WinOTLC / S&P
113.89% / 6.07%
LoseOTLC / S&P
OTLC unavailable / 3.67%
LoseOTLC / S&P
OTLC unavailable / 13.32%
2016-Q40/3 LoseOTLC / S&P
-41.94% / 3.82%
LoseOTLC / S&P
OTLC unavailable / 2.09%
LoseOTLC / S&P
OTLC unavailable / 7.05%
2016-Q30/3 LoseOTLC / S&P
-11.43% / 3.85%
LoseOTLC / S&P
OTLC unavailable / 0.20%
LoseOTLC / S&P
OTLC unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricOTLC total returnS&P 500 Total Return Index
Total return-40.00%20.78%
Annualized return-40.00%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricOTLC total returnS&P 500 Total Return Index
Total return-78.57%83.14%
Annualized return-26.52%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricOTLC total returnS&P 500 Total Return Index
Total return-95.38%319.30%
Annualized return-26.48%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.